1. Fabien Labroussaa
Information acquired: 2025
Fabien Labroussaa is an academic who published a paper in 2024-07-12 entitled A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. The paper was published in a journal entitled Nature Microbiology.